The standout recent finding is the YTD +2.0% return versus a -5.9% market decline, which underscores LILAK's defensive positioning and attractive dividend yield that can provide investors with positive total return in down‑side markets.
A key caution is the persistent negative long‑term total return; over the past decade LILAK has delivered a -15.4% annualized loss, meaning capital appreciation remains weak and any further earnings pressure or dividend cuts could accelerate downside, making it unsuitable for growth‑oriented portfolios.
Despite overall institutional accumulation, the net insider buying of +20.20% is relatively modest when measured against the total float; if insiders were to shift toward selling, a 5‑point swing could quickly erode confidence and trigger a sell‑off, especially given the stock's high volatility.
The stark 33% YoY revenue decline is the most critical growth signal, as it not only erodes current cash generation but also diminishes the base from which any recovery can be built, making a turnaround increasingly dependent on aggressive cost cuts or strategic asset sales.
The negative net margin of -13.8% quantifies a risk where each dollar of revenue generates a $0.14 loss; if operating cash flow does not improve, the firm may face liquidity strain and be forced to raise equity at unfavorable terms, diluting existing shareholders.
The combination of a 17.4‑point margin swing and a 6.2x increase in leverage turned a healthy 21% ROE into a -110% figure, signaling severe equity erosion that threatens dividend sustainability and could trigger covenant breaches.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -110.0 | -13.8 | 0.36 | 22.00 | 14.5 | 7.0 | -5.0 |
| 2024 | -58.6 | -14.7 | 0.35 | 11.42 | -0.5 | -0.4 | -5.1 |
| 2023 | -4.2 | -1.6 | 0.33 | 7.71 | 5.1 | 4.5 | -0.5 |
| 2022 | -8.9 | -3.5 | 0.35 | 7.07 | 0.8 | 0.7 | -1.3 |
| 2021 | -19.8 | -9.2 | 0.31 | 6.92 | 0.6 | 0.5 | -2.9 |
| 2020 | -26.1 | -18.1 | 0.25 | 5.77 | 0.8 | 0.7 | -4.5 |
| 2019 | -3.4 | -2.7 | 0.26 | 4.80 | 2.9 | 2.4 | -0.7 |
| 2018 | -11.1 | -9.3 | 0.28 | 4.32 | -0.2 | -0.2 | -2.6 |
| 2017 | -23.4 | -21.7 | 0.26 | 4.09 | -1.3 | -1.2 | -5.7 |
| 2016 | -6.0 | -9.4 | 0.19 | 3.34 | 2.8 | 2.5 | -1.8 |
| 2015 | 21.3 | 3.6 | 0.37 | 15.83 | 14.0 | 8.7 | 1.3 |
The persistent negative margin (-13.8%) erodes free cash flow generation; if operating losses continue for two quarters, free cash flow could turn negative, forcing the firm to tap debt markets and further inflating the equity multiplier.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1005 | 0 | 75 | 97 | -22 | |
| 2024 | 1048 | 0 | 75 | 333 | 108 | -33 |
| 2023 | 1100 | 0 | 73 | 340 | 103 | -30 |
| 2022 | 1030 | 0 | 61 | 326 | 111 | -50 |
| 2021 | 1166 | 0 | 53 | 316 | 84 | -30 |
| 2020 | 1462 | 0 | 62 | 461 | 122 | -61 |
| 2019 | 1410 | 0 | 55 | 406 | 98 | -43 |
| 2018 | 1324 | 30 | 60 | 417 | 122 | -32 |
| 2017 | 1384 | 27 | 57 | 424 | 119 | -36 |
| 2016 | 1902 | 51 | 83 | 517 | 118 | 15 |
| 2015 | 980 | 19 | 27 | 253 | 37 | 10 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $12226M | $11162M | $556M | $9221M | $9208M | $14M | $2246M | $1978M |
| 2024 | $12800M | $11174M | $1121M | $8168M | $7513M | $654M | $2132M | $2044M |
| 2023 | $13595M | $11285M | $1764M | $8264M | $7276M | $989M | $2412M | $2133M |
| 2022 | $13575M | $11018M | $1919M | $7957M | $7176M | $781M | $2079M | $1774M |
| 2021 | $15366M | $12468M | $2220M | $7648M | $6691M | $957M | $2052M | $1514M |
| 2020 | $15076M | $11736M | $2611M | $8420M | $7526M | $894M | $1948M | $1699M |
| 2019 | $14938M | $10958M | $3110M | $8370M | $7186M | $1184M | $2055M | $1576M |
| 2018 | $13447M | $9323M | $3113M | $6682M | $6051M | $631M | $1645M | $1609M |
| 2017 | $13617M | $8926M | $3330M | $6372M | $5842M | $530M | $1375M | $1587M |
| 2016 | $14192M | $8459M | $4253M | $6048M | $5495M | $553M | $1514M | $1351M |
| 2015 | $3268M | $2998M | $206M | $2335M | $2060M | $274M | $439M | $400M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $806M | $-666M | $30M | $-500M | $306M | ||
| 2024 | $756M | $-688M | $-386M | $-540M | $216M | $-83M | |
| 2023 | $897M | $-616M | $-62M | $-585M | $312M | $-118M | |
| 2022 | $869M | $-1123M | $-29M | $-660M | $209M | $-170M | |
| 2021 | $1016M | $-1269M | $427M | $-736M | $280M | $-63M | |
| 2020 | $640M | $-2451M | $271M | $-566M | $74M | $-10M | |
| 2019 | $918M | $-635M | $1540M | $-589M | $329M | ||
| 2018 | $817M | $-980M | $256M | $-776M | $40M | $-21M | |
| 2017 | $574M | $-640M | $42M | $-639M | $-65M | $-53M | $-55M |
| 2016 | $468M | $-441M | $247M | $-490M | $-22M | $-20M | $-20M |
| 2015 | $306M | $-491M | $364M | $-227M | $79M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net